Marc Whitlow
Enzon Pharmaceuticals, Inc.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marc Whitlow.
Cancer | 1997
Steven M. Larson; Ayda M. El-Shirbiny; Chaitanya R. Divgi; George Sgouros; Ronald D. Finn; Jorg Tschmelitsch; Antonio Picon; Marc Whitlow; Jeffrey Schlom; Jiaju Zhang; Alfred M. Cohen
An sFv fragment of the anti‐TAG‐72 monoclonal antibody CC49 has been developed and has shown promise in improved targeting to colorectal carcinoma in animal studies. In this study the authors report their initial experience in human patients after intravenous injection.
Archive | 1992
Marc Whitlow; James F. Wood; Karl D. Hardman; Robert E. Bird; David Filpula; Michele L. Rollence
Cancer Research | 1992
Takashi Yokota; Diane E. Milenic; Marc Whitlow; Jeffrey Schlom
Cancer Research | 1991
Diane E. Milenic; Takashi Yokota; David Filpula; M. A. J. Finkelman; S. W. Dodd; James F. Wood; Marc Whitlow; P. Snoy; Jeffrey Schlom
Archive | 1997
Marc Whitlow; David Filpula
Archive | 1998
Marc Whitlow; Robert G. L. Shorr; David Filpula; Lihsyng Standford Lee
Protein Engineering | 1994
Marc Whitlow; David Filpula; Michele L. Rollence; Sheau-Line Feng; James F. Wood
Cancer Research | 1993
Takashi Yokota; Diane E. Milenic; Marc Whitlow; James F. Wood; Steven L. Hubert; Jeffrey Schlom
Archive | 1998
David Filpula; Maoliang Wang; Robert G. L. Shorr; Marc Whitlow; Lihsyng S. Lee
Protein Engineering | 1995
Marc Whitlow; Andrew Howard; Jay F. Wood; Edward W. Voss; Karl D. Hardman
